National Institute on Drug Abuse (NIDA)
Government organization
Active
North Bethesda, United States
54
7M
41
1.08
22
0.24
6
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Medical, Non Profit. Among the most popular portfolio startups of the fund, we may highlight Peptide Logic.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The top activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the National Institute on Drug Abuse (NIDA), startups are often financed by National Institutes of Health.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 54
- Lead investments
- 22
- Exits
- 6
- Rounds per year
- 1.08
- Follow on index
- 0.24
- Investments by industry
- Health Care (36)
- Biotechnology (31)
- Pharmaceutical (19)
- Medical (16)
- Medical Device (10) Show 34 more
- Investments by region
-
- United States (51)
- France (1)
- Switzerland (1)
- Japan (1)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Avg. valuation at time of investment
- 1K
- Group Appearance index
- 0.13
- Avg. company exit year
- 2
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Neurotype Inc. | 01 Jul 2023 | Software, Information Technology, Health Care, Medical Device, Neuroscience | Seed | 326K | United States, Minnesota, Minneapolis |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.